Contributors
M . ABERCROMBIE, Department of Zp°l
0
g?*> University College London,
England (p. 177)
J . T . DINGLE, Strangeways Research Laboratory, Cambridge, England (p. 353)
HARRY EAGLE, Department of Cell Biology, Albert Einstein College of Medicine,
New York, U.S.A. (p. 277)
HONOR B. FELL, Strangeways Research Laboratory, Cambridge, England
(p. 659)
H. FIRKET, Laboratoire d'Anatomie pathologique, Universite de Liege, Belgium
(p. 203)
CLIFFORD GROBSTEIN, Department of Biological Sciences, Stanford University,
Stanford, California, U.S.A. (p. 463)
T . C . Hsu, The University of Texas M.D. Anderson Hospital and Tumor
Institute, Houston, Texas, U.S.A. (p. 397)
ILSE LASNITZKI, Strangeways Research Laboratory, Cambridge, England
(p. 591)
LEON LEVINTOW, National Institute of Allergy and Infectious Diseases,
National Institutes of Health, Bethesda, Maryland, U.S.A. (p. 277)
J . A . LUCY, Strangeways Research Laboratory, Cambridge, England (p. 297)
A . A . MOSGONA, Department of Z
00
l°gy> University of Chicago, Chicago,
U.S.A. (pp. 19 and 489)
JOHN PAUL, Department of Biochemistry, The University, Glasgow, Scotland
(p. 239)
L . M . RINALDINI, Instituto de Biologia Celular, Cordoba, Argentina (p. 659)
J . SEED, Department of Radiotherapeutics, University of Cambridge, England
(p. 317)
O . A . TROWELL, M.R.C. Radiobiological Unit, Harwell, England (p. 19)
CHARITY WAYMOUTH, The Jackson Laboratory, Bar Harbor, Maine, U.S.A.
(p. 99)
V